AMGN Amgen: submits data to FDA seeking hearing on tavneos avacopan in response to withdrawal proposal Amgen Inc: strongly disagrees with FD
AMGN Amgen: submits data to FDA seeking hearing on tavneos avacopan in response to withdrawal proposal Amgen Inc: strongly disagrees with FDA's proposal to withdraw tavneos from the U.S. market
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.